Oura and Counsel Partner Through CMS ACCESS Model to Bring AI-Native Chronic Care to Medicare Beneficiaries Using Continuous Biometric Data

Smart wearables have long transitioned from simple step-counters into sophisticated health monitors capable of tracking heart rate variability, sleep stages, skin temperature, and respiratory rates. Yet, a persistent challenge in digital health has been bridging the gap between passive data collection and actionable medical intervention. Patients frequently collect extensive health metrics on their own devices, only to struggle with interpreting these numbers or translating them into meaningful conversations with their primary care physicians.

To address this ongoing disconnect, Oura—the prominent smart ring manufacturer—has announced a major expansion of its existing partnership with Counsel, an artificial intelligence-native primary care provider. This next phase of collaboration involves participation in the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s newly established Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model. By leveraging this federal framework, the two companies aim to study how continuous biometric tracking, when integrated seamlessly with physician-led care, can effectively support Medicare beneficiaries managing prevalent chronic conditions on a large scale.

Beginning in early 2027, Counsel will roll out its AI-native chronic care delivery model targeting specific, high-burden health conditions including hypertension, obesity, hyperlipidemia, and prediabetes. Crucially, this specialized care will be provided at no out-of-pocket cost to eligible Medicare beneficiaries across nearly all United States jurisdictions. The initiative builds directly upon a collaboration launched in May of the previous year, which initially sought to help Oura members transition smoothly from daily health insights to direct clinician action. Through the ACCESS program, both entities are scaling this foundational framework to serve an older, highly vulnerable demographic that stands to gain immensely from proactive, continuous health management.

Chronology of the Partnership and the Evolution of Digital Health Integration

The journey toward this federal integration began earlier in the year when Oura and Counsel first joined forces to tackle the fragmentation between wearable technology and traditional medicine. Historically, users of health-tracking rings and smartwatches reviewed metrics such as resting heart rate or sleep scores independently, leaving them to determine whether an anomalous reading warranted a doctor’s visit. The initial Oura-Counsel integration created a digital bridge: Oura provided members with an ongoing, longitudinal view of subtle physiological shifts, while Counsel’s proprietary medical artificial intelligence and board-certified clinicians helped interpret those signals, providing tailored guidance on necessary next steps.

User reception during the initial months of this integration has been notably positive. Early adopters among the Oura membership base reported significant value in the partnership, frequently highlighting how the service helped demystify complex biometric data and clear a path toward clinical decision-making. Members who utilized the platform to consult directly with a physician rated their overall care experience at an impressive 4.6 out of 5 stars, underscoring both the quality and the convenience of the hybrid AI-and-human care delivery model.

Buoyed by this early success, the transition to the CMS ACCESS Model represents a natural maturation of the partnership. Rather than remaining confined to a standard consumer subscription framework, the collaboration now enters the public health sector, aligning with federal initiatives designed to modernize chronic disease management for aging populations.

Demographic Realities and the Case for Wearables in Medicare

The decision to focus the ACCESS initiative on Medicare beneficiaries is rooted in compelling demographic and health data. Contrary to the assumption that advanced wearable technology is adopted exclusively by younger, tech-savvy demographics, older adults aged 65 and older represent one of Oura’s most highly engaged cohorts, demonstrating exceptional daily application usage and retention rates.

Furthermore, health data within this demographic underscores an urgent need for targeted intervention. Approximately 20 percent of Oura members aged 65 and older present with a Body Mass Index (BMI) of 30 or higher, placing them firmly in the clinical category for obesity and elevating their risk profile for cardiovascular and metabolic disorders. Conditions such as hypertension, prediabetes, and hyperlipidemia are primary drivers of morbidity, mortality, and escalating healthcare expenditures within the United States Medicare system.

By targeting these specific cardio-kidney-metabolic conditions, the ACCESS program addresses the exact health crises that consume a vast majority of Medicare resources. Continuous biometric monitoring offers a distinct clinical advantage over traditional episodic care, which typically relies on infrequent, point-in-time measurements taken during routine doctor visits—such as a blood pressure reading captured during an annual physical. Continuous tracking captures real-world fluctuations driven by stress, sleep disruption, dietary changes, and daily activity, giving physicians a comprehensive, objective timeline of a patient’s physiological state.

How the Program Operates: From Data Stream to Clinical Action

Under the parameters of the ACCESS Model, eligible Medicare beneficiaries who also utilize an Oura Ring will have the option to share their continuous biometric data streams directly with Counsel. Upon consenting to this data sharing, patients receive a deeply personalized care experience informed by real-time health insights generated through the Oura mobile application.

Counsel’s care delivery model uniquely combines advanced medical artificial intelligence with on-demand access to board-certified physicians. The medical AI acts as an initial triage and analytical layer, scanning continuous data streams for concerning trends or deviations from an individual’s personal baseline. When significant patterns emerge, or when patients proactively seek guidance, human physicians step in to provide expert medical oversight, diagnosis, treatment planning, and lifestyle counseling.

This multi-layered approach ensures that clinical resources are deployed efficiently while patients receive prompt, continuous attention. Oura’s role within this ecosystem will primarily be navigational and supportive. The company will utilize the Oura App interface to inform eligible members about the ACCESS program and facilitate introductions to Counsel. However, clinical eligibility verification, enrollment management, and actual healthcare delivery will remain strictly under the independent purview of Counsel’s medical professionals. Detailed instructions regarding the enrollment process for eligible Oura members will be released as the 2027 launch date approaches.

Official Perspectives and Strategic Implications

Industry leaders from both organizations have emphasized the profound public health implications of scaling this integrated model. Dr. Ricky Bloomfield, Chief Medical Officer at Oura, articulated the strategic vision behind the federal expansion, noting that the partnership’s early consumer success laid the groundwork for larger-scale clinical validation.

"Earlier in the year, we partnered with Counsel to help Oura Members move from health insights to clinical action," Dr. Bloomfield stated. "The ACCESS program gives us the opportunity to study that model at scale, and to better understand how continuous biometric data, combined with physician-led care, can support Medicare beneficiaries managing hypertension, obesity, and other early cardio-kidney-metabolic conditions."

From a broader health policy perspective, the integration of consumer wearables into a CMS Innovation Center model reflects a growing recognition within federal agencies that digital health tools can no longer be dismissed as mere lifestyle gadgets. The CMS ACCESS Model is specifically designed to test innovative, scalable solutions that can improve clinical outcomes while reining in the costs associated with chronic disease management. Chronic conditions account for the vast majority of U.S. healthcare spending, and finding effective ways to manage diseases like hypertension and prediabetes before they progress to acute cardiovascular events is a top priority for healthcare administrators and policy makers alike.

Analyzing the Broader Impact on the Healthcare Landscape

The collaboration between Oura and Counsel under the umbrella of the CMS ACCESS Model signals a potential turning point for the intersection of consumer technology, artificial intelligence, and federal healthcare programs. For years, the digital health sector operated largely in parallel to traditional clinical medicine, with consumer apps and wearables generating vast quantities of data that primary care doctors often lacked the time, tools, or financial incentives to review.

By embedding AI-native primary care directly into a federally backed chronic care framework, this initiative establishes a replicable blueprint for how consumer hardware companies can partner with clinical providers to satisfy rigorous regulatory and quality standards. If the ACCESS Model study successfully demonstrates that continuous biometric data reduces hospitalizations, improves biomarker control, and enhances patient satisfaction among Medicare beneficiaries, it could accelerate the broader adoption and reimbursement of digital health interventions across the entire healthcare system.

Furthermore, the integration of artificial intelligence into primary care workflows represents a vital coping mechanism for a healthcare industry currently grappling with physician shortages and clinician burnout. By utilizing medical AI to preprocess continuous data streams and flag critical health changes, physicians can focus their finite time and expertise on direct patient interaction and complex decision-making.

As the healthcare industry looks toward the official 2027 launch of Counsel’s ACCESS care delivery program, the partnership between Oura and Counsel stands out as a pioneering effort to harmonize consumer health tracking with evidence-based medicine. For millions of older Americans managing chronic conditions, the initiative promises a future where advanced technology and compassionate, physician-led care converge to deliver unprecedented support right when it is needed most.